Abstract
The successful implementation of biomodulatory therapies for controlling a wide variety of metastatic types of cancer has been demonstrated in multiple clinical phase II trials. These therapies have opened up new perspectives for studying novel tumor models, which may explain response to combined biomodulatory therapies. Hereby, insights in evolutionary systems structures have become possible.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Netherlands
About this chapter
Cite this chapter
Reichle, A., Hildebrandt, G.C. (2010). From Molecular to Modular, from Theme-Dependent to Evolution-Adjusted Tumor Therapy. In: Reichle, A. (eds) From Molecular to Modular Tumor Therapy. The Tumor Microenvironment, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9531-2_27
Download citation
DOI: https://doi.org/10.1007/978-90-481-9531-2_27
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9530-5
Online ISBN: 978-90-481-9531-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)